Kazazian Asset Management, LLC - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 175 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.7%.

Quarter-by-quarter ownership
Kazazian Asset Management, LLC ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$326,000
-63.5%
9,021
-37.9%
0.44%
-47.3%
Q3 2018$894,000
-25.0%
14,517
-17.8%
0.84%
-23.4%
Q2 2018$1,192,000
+19.9%
17,650
-3.7%
1.09%
+4.9%
Q1 2018$994,000
+33.4%
18,321
+47.0%
1.04%
+36.9%
Q4 2017$745,000
+5.2%
12,466
-14.5%
0.76%
-12.2%
Q3 2017$708,000
+57.3%
14,577
+70.3%
0.87%
+27.3%
Q2 2017$450,0008,5580.68%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 1,464,749$98,944,00034.86%
Foresite Capital Management III, LLC 1,708,046$115,379,00024.85%
Eversept Partners, LP 226,902$15,327,2307.01%
SECTORAL ASSET MANAGEMENT INC 615,870$41,602,0004.65%
DAFNA Capital Management LLC 131,770$8,901,0004.17%
PACIFIC VIEW ASSET MANAGEMENT, LLC 68,666$4,638,0003.67%
Asymmetry Capital Management, L.P. 49,756$3,361,0003.30%
PFM Health Sciences, LP 2,720,218$183,751,0002.88%
HealthCor Management, L.P. 1,314,290$88,780,0002.82%
Boulegeris Investments, Inc. 66,540$4,495,0002.25%
View complete list of AERIE PHARMACEUTICALS INC shareholders